CompletedNCT06725771
A Non-randomized Controlled Trial Was Conducted to Observe the Improvement in the Level of HAMA in Patients With Generalized Anxiety Disorder During the 6-week Period of Oral Treatment With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction) Combined With Sertraline.
Medication studyAges 18–80China
Understand this study
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 80 years. Other eligibility criteria applied.
- Listed locations
- NanjingSee all locations and recruitment
Study information
Study start dateStarted: September 1, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 205
- Sponsor
- Lin Xiaoqian
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT06725771
- Official title
Show the full official title
Clinical Study on the Treatment of Generalized Anxiety Disorder With Chaihu Jia Longgu Muli Tang (Bupleurum Plus Dragon Bone and Oyster Shell Decoction)
Get this study by email
Recruitment & locations
CompletedNanjing
Questions about this study
Who is behind this study?
The study sponsor is Lin Xiaoqian.
Did this study involve medication?
Yes. The study involved medication, including Bupleurum Plus Dragon Bone and Oyster Shell Decoction Combined with Sertraline and Sertraline Hydrochloride Tablets.
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 80 years. Other eligibility criteria applied.
Want to explore more studies?
Explore studiesRelated studies
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers